Martin Hirsch

February 6, 2023

Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study

Abstract Objective: Cannabidiol (CBD) is approved for treatment of Dravet syndrome (DS), Lennox‐Gastaut syndrome (LGS), and tuberous sclerosis complex (TSC).…

December 10, 2019

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy

Abstract Objective: Controlled and open label trials have demonstrated efficacy of cannabidiol for certain epileptic encephalopathies. However, plant derived cannabidiol…